Deepull
Founded 2019 · 71 employees on LinkedIn · 5 known investors
Find your way into Deepull
Sign up to see every warm intro you have to Deepull
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Deepull team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Deepull develops a multiplex PCR diagnostic system to rapidly identify sepsis-causing pathogens and antibiotic resistance markers directly from blood samples in approximately one hour, targeting hospitals and clinical laboratories.
Investors · 5
How we know: Asabys Partners's portfolio page · a partner's Signal profile · the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: a partner's Signal profile · Not right? Tell us
How we know: funding news · Not right? Tell us
Funding
SEC filings, press & company announcements- Undisclosed amountSeries CApr 2025Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Frequently asked questions
- What does Deepull do?
- Deepull develops a multiplex PCR diagnostic system to rapidly identify sepsis-causing pathogens and antibiotic resistance markers directly from blood samples in approximately one hour, targeting hospitals and clinical laboratories.
- Who are Deepull's investors?
- Deepull's investors include Asabys Partners, Alta Life Sciences, Columbus Venture Partners, Kurma Partners, Panakes Partners.



